269 related articles for article (PubMed ID: 16328385)
1. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
[TBL] [Abstract][Full Text] [Related]
2. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
[TBL] [Abstract][Full Text] [Related]
3. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.
Liu L; Yao J; Ding Q; Huang S
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):548-51. PubMed ID: 17219964
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the CD4+CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma.
Wang G; Sun Y; Ji C; He Y; Hu C; Jiang F; Chen M; Duan Q; Fan P; Hu B
Hepatogastroenterology; 2013 Jun; 60(124):704-8. PubMed ID: 23262265
[TBL] [Abstract][Full Text] [Related]
6. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
7. [CD4+CD25high regulatory cells in peripheral blood of nasopharyngeal carcinoma].
Liu L; Yao J; Ding Q; Cao R; Wang J; Huang S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Oct; 19(20):929-31. PubMed ID: 16398048
[TBL] [Abstract][Full Text] [Related]
8. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
[TBL] [Abstract][Full Text] [Related]
10. CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy.
Xu T; Duan Q; Wang G; Hu B
Cell Biochem Biophys; 2011 Nov; 61(2):389-92. PubMed ID: 21607687
[TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
12. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease.
Araujo FF; Gomes JA; Rocha MO; Williams-Blangero S; Pinheiro VM; Morato MJ; Correa-Oliveira R
Front Biosci; 2007 May; 12():2797-806. PubMed ID: 17485260
[TBL] [Abstract][Full Text] [Related]
13. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
[TBL] [Abstract][Full Text] [Related]
14. CD4
Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
[TBL] [Abstract][Full Text] [Related]
15. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
Bacchetta R; Passerini L; Gambineri E; Dai M; Allan SE; Perroni L; Dagna-Bricarelli F; Sartirana C; Matthes-Martin S; Lawitschka A; Azzari C; Ziegler SF; Levings MK; Roncarolo MG
J Clin Invest; 2006 Jun; 116(6):1713-22. PubMed ID: 16741580
[TBL] [Abstract][Full Text] [Related]
16. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Haas J; Hug A; Viehöver A; Fritzsching B; Falk CS; Filser A; Vetter T; Milkova L; Korporal M; Fritz B; Storch-Hagenlocher B; Krammer PH; Suri-Payer E; Wildemann B
Eur J Immunol; 2005 Nov; 35(11):3343-52. PubMed ID: 16206232
[TBL] [Abstract][Full Text] [Related]
17. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
18. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.
Tsunemi S; Iwasaki T; Imado T; Higasa S; Kakishita E; Shirasaka T; Sano H
AIDS; 2005 Jun; 19(9):879-86. PubMed ID: 15905668
[TBL] [Abstract][Full Text] [Related]
19. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.
Gregg R; Smith CM; Clark FJ; Dunnion D; Khan N; Chakraverty R; Nayak L; Moss PA
Clin Exp Immunol; 2005 Jun; 140(3):540-6. PubMed ID: 15932517
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral glucocorticoid therapy on CD4+CD25+CD127- and CD4+CD25high T cell levels in asthmatic patients.
Moniuszko M; Bodzenta-Lukaszyk A; Dabrowska M
Inflammation; 2010 Dec; 33(6):415-20. PubMed ID: 20300815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
